Xiaoshuang Wang

2PUBLICATIONS
12CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Mar 26, 2021
BCL9/BCL9L promotes tumorigenicity through immune-dependent and independent mechanisms in triple negative breast cancer.

Xiaoshuang Wang, Mei Feng, Tengfei Xiao

|May 16, 2019
Pharmacological inhibition of β-catenin/BCL9 interaction overcomes resistance to immune checkpoint blockades by modulating Treg cells.

M Feng, J Q Jin, L Xia

Pageof 1

Frequent Collaborators

2 joint publications

Di Zhu

1 joint publications

M Feng

1 joint publications

J Q Jin

1 joint publications

L Xia